Although TXA2 and PGH2 are believed to be involved in the process of hemostasis and the genesis of certain forms of cardiovascular disease, little is known concerning the specific mechanisms by which TXA2/PGH2- receptor interaction leads to the modulation of platelet function. This lack of information is primarily due to two considerations: 1. the multiple feedback mechanisms which exist within platelets; and 2. the unavailability of purified signal transduction components, e.g., receptor protein, associated G-proteins, etc. Thus in a highly-coupled, positive feedback system, as apparently occurs in the TXA2/PGH2 pathway, pharmacological intervention at one site will undoubtedly effect multiple biochemical processes at additional sites. This, in turn, significantly complicates interpretation of the observed results. Based on this consideration, the most definitive approach to studying TXA2/PGH2 signal transduction would be to identify, isolate and characterize the primary components involved in this pathway. Once this has been accomplished one can begin to examine pharmacological and physiological modulation the reconstituted components in the absence of extraneous influences. The present application proposes to characterize the TXA2/PGH2 signal transduction pathway using this approach. Specifically, studies are designed to: 1. raise antipeptide and monoclonal antibodies libraries which will be used to probe TXA2/PGH2 receptors and their associated G- proteins; 2. purify TXA2/PGH2 receptors by affinity chromatography procedures; 3. purify, identify and characterize receptor-associated G- proteins; 4. define receptor/G-protein coupling domains; 4; identify cAMP/cGMP-mediated phosphorylation sites on the TXA2/PGH2 receptor/G- protein complex; 5. investigate the relationship between such phosphorylation and coupling of the receptor/G-protein complex in a reconstituted system; 6. apply specific photoaffinity ligand techniques to irreversibly label platelets. TXA2/PGH2 receptors, and identify the receptor ligand binding domains; and 7. utilize a newly synthesized, biotinylated TXA2/P6H2 receptor antagonist (in conjunction with antibodies) to label and define receptor location/distribution in resting and activated platelets. These studies represent a rigorous and in-depth characterization of human platelet TXA2/PGH2 receptors and the signal transduction mechanisms specifically involved in this pathway. The feasibility of these studies is great strengthened by the current availability of purified receptor/G- proteins, high affinity TXA2/PGH2 analogs receptor/G-protein-specific antibodies and substantial preliminary data. On this basis, it is anticipated that these studies will be of significant value in more clearly defining the underlying mechanisms of TXA2/PGH2-mediated platelet activation and, in turn, novel therapeutic approaches to the treatment of thromboembolic disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL024530-16
Application #
2609203
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1987-09-30
Project End
1999-06-30
Budget Start
1997-12-01
Budget End
1999-06-30
Support Year
16
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Miscellaneous
Type
Schools of Allied Health Profes
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Schiemer, James; Bohm, Andrew; Lin, Li et al. (2016) G?13 Switch Region 2 Relieves Talin Autoinhibition to Activate ?IIb?3 Integrin. J Biol Chem 291:26598-26612
Srinivasan, Subhashini; Schiemer, James; Zhang, Xiaowei et al. (2015) G?13 Switch Region 2 Binds to the Talin Head Domain and Activates ?IIb?3 Integrin in Human Platelets. J Biol Chem 290:25129-39
Wieschhaus, Adam J; Le Breton, Guy C; Chishti, Athar H (2012) Headpiece domain of dematin regulates calcium mobilization and signaling in platelets. J Biol Chem 287:41218-31
Qian, Feng; Le Breton, Guy C; Chen, Jia et al. (2012) Role for the guanine nucleotide exchange factor phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchanger 1 in platelet secretion and aggregation. Arterioscler Thromb Vasc Biol 32:768-77
Xie, An; Yan, Jun; Yue, Lan et al. (2011) 2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-?1 receptors. Mol Pharmacol 80:965-78
Gussin, Hélène A; Khasawneh, Fadi T; Xie, An et al. (2011) Subunit-specific polyclonal antibody targeting human ?1 GABA(C) receptor. Exp Eye Res 93:59-64
Nie, Baoming; Cheng, Ni; Dinauer, Mary C et al. (2010) Characterization of P-Rex1 for its role in fMet-Leu-Phe-induced superoxide production in reconstituted COS(phox) cells. Cell Signal 22:770-82
Huang, Jin-Sheng; Dong, Lanlan; Kozasa, Tohru et al. (2007) Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion. J Biol Chem 282:10210-22
Huang, Jin-Sheng; Dong, Lanlan; Le Breton, Guy C (2006) Mass-dependent signaling between G protein coupled receptors. Cell Signal 18:564-76
Manganello, Jeanne M; Huang, Jin-Sheng; Kozasa, Tohru et al. (2003) Protein kinase A-mediated phosphorylation of the Galpha13 switch I region alters the Galphabetagamma13-G protein-coupled receptor complex and inhibits Rho activation. J Biol Chem 278:124-30

Showing the most recent 10 out of 34 publications